☆ 4.4 Article

Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payerʼs Perspective

PHARMACOECONOMICS (2011)

Get Full Text
Add to Collection

Journal

PHARMACOECONOMICS
Volume 30, Issue 2, Pages 87-101

Publisher

Springer Nature
DOI: 10.2165/11599370-000000000-00000

Keywords

-

Categories

Economics

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.